CY1111250T1 - Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων - Google Patents

Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων

Info

Publication number
CY1111250T1
CY1111250T1 CY20111100060T CY111100060T CY1111250T1 CY 1111250 T1 CY1111250 T1 CY 1111250T1 CY 20111100060 T CY20111100060 T CY 20111100060T CY 111100060 T CY111100060 T CY 111100060T CY 1111250 T1 CY1111250 T1 CY 1111250T1
Authority
CY
Cyprus
Prior art keywords
group
hydrogen atom
ring
atom
bond
Prior art date
Application number
CY20111100060T
Other languages
English (en)
Inventor
Kazuhiko Ohrai
Yukihiro Shigeta
Osamu Uesugi
Takumi Okada
Tomoyuki Matsuda
Original Assignee
Nissan Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Industries, Ltd. filed Critical Nissan Chemical Industries, Ltd.
Publication of CY1111250T1 publication Critical patent/CY1111250T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τα παράγωγα του βενζοπυρανίου του τύπου (I) ή (II), ή φαρμακευτικά αποδεχτά άλατα σχετικά με αυτά όπου τα R1 και R2 είναι, ανεξάρτητα το ένα από το άλλο, άτομο υδρογόνου, C1-6 αλκυλομάδα ή C6-14 αρυλομάδα, το R3 είναι άτομο υδρογόνου ή C1-6 αλκυλοκαρβονυλοξυομάδα ή σχηματίζει ένα δεσμό μαζί με το R4, το R4 είναι άτομο υδρογόνου ή σχηματίζει ένα δεσμό μαζί με το R3, το «m» είναι ένας ακέραιος αριθμός από το 0-4, το «n» είναι ένας ακέραιος αριθμός από το 0-4, το «V» είναι ένας μονός δεσμός, CR7R8, NR9, Ο, S, SO ή SO2, το R5 είναι άτομο υδρογόνου ή C1-6 αλκυλομάδα, το R6 είναι άτομο υδρογόνου, C1-6 αλκυλομάδα, C3-8 κυκλοαλκυλομάδα, C3-8 κυκλοαλκενυλομάδα, αμινομάδα, C1-6 αλκυλαμινομάδα, δι- C1-6, αλκυλαμινομάδα, C6-14 αρυλαμινομάδα, C2-9 ετεροαρυλαμινομάδα, C6-14 αρυλομάδα, C2-9 ετεροαρυλομάδα ή C2-9 ετεροκυκλυλομάδα, το Α είναι 5-μελής, 6-μελής ή 7-μελής δακτύλιος συζευγμένος με δακτύλιο βενζολίου, ως συστατικό άτομο του δακτυλίου, το άτομο οξυγόνου, το άτομο αζώτου, ή το άτομο θείου μπορεί να περιλαμβάνονται στον αριθμό 1 έως 3 μόνα τους ή σε συνδυασμό σχετικά με αυτά, ο αριθμός του ακόρεστου δεσμού στο δακτύλιο είναι 1, 2 ή 3 συμπεριλαμβανομένου ενός ακόρεστου δεσμού του δακτυλίου του βενζολίου για σύζευξη, τα άτομα άνθρακα που αποτελούν το δακτύλιο μπορεί να είναι καρβονυλικά ή θειοκαρβονυλικά. Οι παρούσες ενώσεις είναι χρήσιμες ως ένας αντιαρρυθμικός παράγοντας.
CY20111100060T 2004-03-23 2011-01-19 Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων CY1111250T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
EP05727581A EP1732929B1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (1)

Publication Number Publication Date
CY1111250T1 true CY1111250T1 (el) 2015-06-11

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100060T CY1111250T1 (el) 2004-03-23 2011-01-19 Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων

Country Status (31)

Country Link
US (2) US7652008B2 (el)
EP (1) EP1732929B1 (el)
JP (1) JP4840594B2 (el)
KR (2) KR101019402B1 (el)
CN (3) CN1934116B (el)
AT (1) ATE485299T1 (el)
AU (2) AU2005223612B2 (el)
BR (1) BRPI0508768A (el)
CA (1) CA2558139C (el)
CY (1) CY1111250T1 (el)
CZ (1) CZ2006598A3 (el)
DE (1) DE602005024245D1 (el)
DK (1) DK1732929T3 (el)
EG (1) EG27163A (el)
ES (1) ES2353021T3 (el)
HK (1) HK1099299A1 (el)
HR (1) HRP20110005T1 (el)
IL (1) IL177950A (el)
MX (1) MXPA06010880A (el)
NO (1) NO339495B1 (el)
NZ (2) NZ585606A (el)
PL (1) PL1732929T3 (el)
PT (1) PT1732929E (el)
RS (1) RS51742B (el)
RU (1) RU2380370C2 (el)
SI (1) SI1732929T1 (el)
SK (1) SK287994B6 (el)
TW (1) TWI352704B (el)
UA (1) UA91189C2 (el)
WO (1) WO2005090357A1 (el)
ZA (1) ZA200607388B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005024245D1 (de) * 2004-03-23 2010-12-02 Nissan Chemical Ind Ltd Tricyclische benzopyranverbindungen als antiarrhythmika
AU2007225765B2 (en) 2006-03-10 2012-05-24 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
CN102414213B (zh) 2009-04-30 2014-12-24 日产化学工业株式会社 三环苯并吡喃化合物的新的晶形及其制造方法
EP3309151A1 (en) * 2009-06-25 2018-04-18 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
JP6202280B2 (ja) * 2012-09-27 2017-09-27 日産化学工業株式会社 含窒素複素環n−オキシド化合物の製造方法
WO2014051077A1 (ja) * 2012-09-27 2014-04-03 日産化学工業株式会社 高純度の含窒素複素環化合物の製造方法
JPWO2015012271A1 (ja) * 2013-07-25 2017-03-02 日産化学工業株式会社 複素環化合物の製造方法
EP3567044A4 (en) 2017-01-06 2020-06-10 Korea University Research and Business Foundation, Sejong Campus INNOVATIVE CHINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES LIKE ASTHMA OR ATOPIA THEREFORE AS AN ACTIVE SUBSTANCE
AU2019230014A1 (en) 2018-03-05 2020-09-17 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
WO2020138428A1 (ja) * 2018-12-28 2020-07-02 国立大学法人大阪大学 遺伝性徐脈性不整脈治療薬
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
TW202214582A (zh) * 2020-06-26 2022-04-16 國立大學法人大阪大學 藥劑誘發性心律過慢及心律過慢性心律不整治療藥

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5097037A (en) 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
US5164509A (en) 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
AU677643B2 (en) 1993-04-02 1997-05-01 Nissan Chemical Industries Ltd. Heart failure remedy
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
DE69518322T2 (de) 1994-06-10 2001-02-15 Smithkline Beecham Plc C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel
TW496866B (en) * 1996-05-15 2002-08-01 Hoechst Ag Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them
CA2334412A1 (en) 1998-06-03 1999-12-09 Nissan Chemical Industries, Ltd. Indan derivatives
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
WO2000058300A1 (fr) 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Derives du chroman
SK3292002A3 (en) 1999-09-17 2003-04-01 Nissan Chemical Ind Ltd Benzopyran derivative
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
AU7453900A (en) 1999-10-05 2001-05-10 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
CN1279036C (zh) 2001-06-25 2006-10-11 日产化学工业株式会社 抗心律失常的取代的苯并吡喃衍生物
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
DE602005024245D1 (de) * 2004-03-23 2010-12-02 Nissan Chemical Ind Ltd Tricyclische benzopyranverbindungen als antiarrhythmika

Also Published As

Publication number Publication date
NO20064819L (no) 2006-10-23
DE602005024245D1 (de) 2010-12-02
ZA200607388B (en) 2008-07-30
RS51742B (en) 2011-10-31
NZ585606A (en) 2011-11-25
SK287994B6 (sk) 2012-09-03
NZ549570A (en) 2010-08-27
AU2005223612A1 (en) 2005-09-29
US7964623B2 (en) 2011-06-21
JP2007530436A (ja) 2007-11-01
CN102190661B (zh) 2013-07-31
TWI352704B (en) 2011-11-21
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
US7652008B2 (en) 2010-01-26
SK50792006A3 (sk) 2007-09-06
KR101085979B1 (ko) 2011-11-22
AU2005223612B2 (en) 2010-06-24
BRPI0508768A (pt) 2007-02-27
AU2010202900A1 (en) 2010-07-29
CN1934116B (zh) 2012-10-10
CN101429200A (zh) 2009-05-13
SI1732929T1 (sl) 2010-12-31
CN1934116A (zh) 2007-03-21
AU2010202900B2 (en) 2011-10-27
DK1732929T3 (da) 2010-12-20
EP1732929B1 (en) 2010-10-20
ATE485299T1 (de) 2010-11-15
IL177950A (en) 2013-04-30
US20100069374A1 (en) 2010-03-18
JP4840594B2 (ja) 2011-12-21
IL177950A0 (en) 2006-12-31
HK1099299A1 (en) 2007-08-10
CA2558139C (en) 2012-01-17
RU2380370C2 (ru) 2010-01-27
UA91189C2 (en) 2010-07-12
KR20070009638A (ko) 2007-01-18
US20080004262A1 (en) 2008-01-03
WO2005090357A1 (en) 2005-09-29
EP1732929A1 (en) 2006-12-20
CN101429200B (zh) 2012-05-30
HRP20110005T1 (hr) 2011-02-28
MXPA06010880A (es) 2006-12-15
CN102190661A (zh) 2011-09-21
CZ2006598A3 (cs) 2006-11-15
NO339495B1 (no) 2016-12-19
PT1732929E (pt) 2010-12-21
RU2006137284A (ru) 2008-04-27
EG27163A (en) 2015-08-24
TW200600509A (en) 2006-01-01
PL1732929T3 (pl) 2011-04-29
CA2558139A1 (en) 2005-09-29
ES2353021T3 (es) 2011-02-24

Similar Documents

Publication Publication Date Title
CY1111250T1 (el) Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων
BG107120A (en) Novel, slow-acting betamimetics, a method for their production and their use as medicaments
MY139988A (en) Macrocylic inhibitors of hepatitis c virus
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
HUP0202799A2 (hu) Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény
MX9504287A (es) Derivados de camptotecina y proceso para su preparacion.
CY1109222T1 (el) Παραγωγο συγχωνευμενης κινολινης και χρηση του
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
EP1719761A4 (en) NEW HETEROCYCLIC CONNECTION
NZ505927A (en) Cyclobutene-1,2-dione derivatives for use in the inhibition of an ileal bile acid transporter
HUP0203839A2 (hu) 4-Fenil-1-piperazinil-, -piperidinil- és tetrahidropiridil-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
NZ245783A (en) Benzopyran and dibenzopyran derivatives as intermediates
MXPA02007973A (es) Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece.
EP0999211A4 (en) PURINE DERIVATIVES AND THEIR MEDICINAL APPLICATION
IL136510A (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
CA2440186A1 (en) Medicinal composition containing 1,3-thiazine derivative
WO1999005165A8 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
DK1546096T3 (da) Fremgangsmåde til fremstilling af aminopyrrolidinderivater
AR034088A1 (es) Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
UY26245A1 (es) Nuevos derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen art 127 de la ley 17164
TH61861A3 (th) 4-ออกโซ-1,4-ไดไฮโดร-3-ควิโนลีนคาร์บอกซามีดที่เป็นตัวกระทำต้านเชื้อไวรัส
ECSP992984A (es) Derivados de isotiazol utiles como agentes anticancerosos
TH25178B (th) สารประกอบประเภทใหม่